CereVasc Revenue and Competitors
Estimated Revenue & Valuation
- CereVasc's estimated annual revenue is currently $2.1M per year.
- CereVasc's estimated revenue per employee is $125,500
- CereVasc's total funding is $44M.
Employee Data
- CereVasc has 17 Employees.
- CereVasc grew their employee count by 31% last year.
CereVasc Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $9.5M | 38 | 3% | N/A | N/A |
#2 | $8.3M | 33 | 14% | N/A | N/A |
#3 | $4M | 16 | 33% | N/A | N/A |
#4 | $4.3M | 17 | -6% | N/A | N/A |
#5 | $5630M | 6953 | 4% | $450M | N/A |
#6 | $4M | 16 | 33% | N/A | N/A |
#7 | $7.2M | 57 | 27% | $29.6M | N/A |
#8 | $14.1M | 56 | 0% | N/A | N/A |
#9 | $2.1M | 17 | 31% | $44M | N/A |
#10 | $40.9M | 163 | -23% | N/A | N/A |
What Is CereVasc?
CereVasc, Inc. is developing the eShuntâ„¢ System for the treatment of patients with communicating hydrocephalus, one of the most common neurological conditions affecting both children and adults.
keywords:N/A
$44M
Total Funding
17
Number of Employees
$2.1M
Revenue (est)
31%
Employee Growth %
N/A
Valuation
N/A
Accelerator
CereVasc News
Clinical trial underway in Argentina to study minimally invasive treatment for NPH. BOSTON, April 25, 2022 /PRNewswire/ -- CereVasc, Inc.,...
CereVasc, Inc., a Boston, MA-based company focused on improving the treatment of patients with hydrocephalus, closed an expanded Series A financing that raised a total of $43.9m. The round was led by the Perceptive Xontogeny Venture (PXV) Fund and ATON Partners, LLC. Led by Dan Levangie, Chair ...
BOSTON--(BUSINESS WIRE)--CereVasc, Inc., a company focused on improving the treatment of patients with hydrocephalus, announced today the closing of an expanded Series A financing that raised a total of $43.9 million led by the Perceptive Xontogeny Venture (PXV) Fund and ATON Partners, LLC. The ...
– Proceeds to fund clinical trials of the eShunt™ System for treatment of hydrocephalus – – Series A financing led by the Perceptive Xontogeny Venture Fund – BOSTON–(BUSINESS WIRE)–June 9, 2020– CereVasc, Inc., a company focused on improving the treatment of patients with hydrocephalus, annou ...
Other Companies in Auburndale
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $5M | 25 | 0% | N/A |
#2 | $3.4M | 35 | 3% | N/A |
#3 | $4.4M | 46 | 2% | N/A |
#4 | $5.8M | 48 | -13% | N/A |
#5 | $8.6M | 49 | 7% | N/A |